mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-10 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-10 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-10 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
9e-10 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-09 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
2e-09 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-09 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
4e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-09 |